Xponance Inc. Purchases 46,364 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Xponance Inc. raised its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 46.2% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 146,719 shares of the real estate investment trust's stock after purchasing an additional 46,364 shares during the quarter. Xponance Inc.'s holdings in Healthpeak Properties were worth $2,967,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in DOC. Norges Bank bought a new stake in Healthpeak Properties in the fourth quarter valued at about $166,804,000. Resolution Capital Ltd bought a new stake in Healthpeak Properties during the fourth quarter worth about $122,795,000. Long Pond Capital LP bought a new stake in Healthpeak Properties during the fourth quarter worth about $86,885,000. Northern Trust Corp grew its stake in Healthpeak Properties by 32.6% during the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after buying an additional 2,590,530 shares during the last quarter. Finally, National Bank of Canada FI grew its stake in Healthpeak Properties by 56,120.9% during the fourth quarter. National Bank of Canada FI now owns 1,686,065 shares of the real estate investment trust's stock worth $34,181,000 after buying an additional 1,683,066 shares during the last quarter. Institutional investors own 93.57% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on DOC. Wedbush decreased their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Wells Fargo & Company decreased their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Evercore ISI decreased their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Robert W. Baird decreased their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. Finally, Scotiabank decreased their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research note on Monday, May 12th. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $23.27.

Insiders Place Their Bets

In other Healthpeak Properties news, Director John T. Thomas bought 4,200 shares of the stock in a transaction on Monday, April 28th. The stock was purchased at an average price of $17.84 per share, with a total value of $74,928.00. Following the acquisition, the director owned 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Scott M. Brinker bought 2,750 shares of the stock in a transaction on Friday, May 9th. The shares were acquired at an average cost of $17.39 per share, with a total value of $47,822.50. Following the acquisition, the chief executive officer directly owned 204,613 shares in the company, valued at approximately $3,558,220.07. This trade represents a 1.36% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 29,764 shares of company stock valued at $521,909. Company insiders own 0.23% of the company's stock.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock traded down $0.31 during midday trading on Tuesday, reaching $18.23. The company had a trading volume of 4,857,818 shares, compared to its average volume of 5,361,044. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.01. The company has a market capitalization of $12.66 billion, a price-to-earnings ratio of 45.58, a price-to-earnings-growth ratio of 2.11 and a beta of 1.03. The stock has a fifty day simple moving average of $17.51 and a 200 day simple moving average of $18.93. Healthpeak Properties, Inc. has a 1-year low of $16.64 and a 1-year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The firm had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. During the same quarter in the previous year, the business earned $0.45 EPS. The business's quarterly revenue was up 15.9% compared to the same quarter last year. As a group, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Friday, September 19th will be issued a dividend of $0.1017 per share. This represents a $1.22 dividend on an annualized basis and a yield of 6.69%. The ex-dividend date is Friday, September 19th. Healthpeak Properties's dividend payout ratio is presently 305.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.